These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24292889)

  • 21. Loss of nuclear UBE3A causes electrophysiological and behavioral deficits in mice and is associated with Angelman syndrome.
    Avagliano Trezza R; Sonzogni M; Bossuyt SNV; Zampeta FI; Punt AM; van den Berg M; Rotaru DC; Koene LMC; Munshi ST; Stedehouder J; Kros JM; Williams M; Heussler H; de Vrij FMS; Mientjes EJ; van Woerden GM; Kushner SA; Distel B; Elgersma Y
    Nat Neurosci; 2019 Aug; 22(8):1235-1247. PubMed ID: 31235931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ubiquitin-protein ligase E3A (UBE3A) mediation of viral infection and human diseases.
    Chaudhary P; Proulx J; Park IW
    Virus Res; 2023 Oct; 335():199191. PubMed ID: 37541588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.
    LaSalle JM; Reiter LT; Chamberlain SJ
    Epigenomics; 2015 Oct; 7(7):1213-28. PubMed ID: 26585570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interlinked destinies: How ubiquitin-proteasome and autophagy systems underpin neurocognitive outcomes.
    Yang X; Duckhorn J; Marshall J; Huang YA
    Exp Neurol; 2024 Sep; 379():114869. PubMed ID: 38901755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants.
    Offensperger F; Müller F; Jansen J; Hammler D; Götz KH; Marx A; Sirois CL; Chamberlain SJ; Stengel F; Scheffner M
    Cell Chem Biol; 2020 Dec; 27(12):1510-1520.e6. PubMed ID: 32966807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of ubiquitin ligase E3A in polarized contact guidance and rescue strategies in UBE3A-deficient hippocampal neurons.
    Tonazzini I; Van Woerden GM; Masciullo C; Mientjes EJ; Elgersma Y; Cecchini M
    Mol Autism; 2019; 10():41. PubMed ID: 31798818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UBE3A reinstatement as a disease-modifying therapy for Angelman syndrome.
    Elgersma Y; Sonzogni M
    Dev Med Child Neurol; 2021 Jul; 63(7):802-807. PubMed ID: 33543479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
    Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
    Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/β-catenin pathway by inhibiting the proteasome.
    Yi JJ; Paranjape SR; Walker MP; Choudhury R; Wolter JM; Fragola G; Emanuele MJ; Major MB; Zylka MJ
    J Biol Chem; 2017 Jul; 292(30):12503-12515. PubMed ID: 28559284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome.
    Wang T; Wang J; Wang J; Mao L; Tang B; Vanderklish PW; Liao X; Xiong ZQ; Liao L
    Neurobiol Dis; 2019 Dec; 132():104585. PubMed ID: 31445164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Autism-Linked Mutation Disables Phosphorylation Control of UBE3A.
    Yi JJ; Berrios J; Newbern JM; Snider WD; Philpot BD; Hahn KM; Zylka MJ
    Cell; 2015 Aug; 162(4):795-807. PubMed ID: 26255772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angelman syndrome scientific symposium on the structure and function of UBE3A/E6AP.
    Williams C
    J Child Neurol; 2009 Jul; 24(7):904-8. PubMed ID: 19617463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UBE3A-mediated PTPA ubiquitination and degradation regulate PP2A activity and dendritic spine morphology.
    Wang J; Lou SS; Wang T; Wu RJ; Li G; Zhao M; Lu B; Li YY; Zhang J; Cheng X; Shen Y; Wang X; Zhu ZC; Li MJ; Takumi T; Yang H; Yu X; Liao L; Xiong ZQ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12500-12505. PubMed ID: 31160454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential therapeutic approaches for Angelman syndrome.
    Bi X; Sun J; Ji AX; Baudry M
    Expert Opin Ther Targets; 2016; 20(5):601-13. PubMed ID: 26558806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation.
    Condon KH; Ho J; Robinson CG; Hanus C; Ehlers MD
    J Neurosci; 2013 Feb; 33(9):3799-814. PubMed ID: 23447592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation.
    Low D; Chen KS
    Eur J Hum Genet; 2010 Nov; 18(11):1228-35. PubMed ID: 20571502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UBE3A regulates MC1R expression: a link to hypopigmentation in Angelman syndrome.
    Low D; Chen KS
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):944-52. PubMed ID: 21733131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion.
    Dodge A; Peters MM; Greene HE; Dietrick C; Botelho R; Chung D; Willman J; Nenninger AW; Ciarlone S; Kamath SG; Houdek P; Sumová A; Anderson AE; Dindot SV; Berg EL; O'Geen H; Segal DJ; Silverman JL; Weeber EJ; Nash KR
    Autism Res; 2020 Mar; 13(3):397-409. PubMed ID: 31961493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Scalable, Cell-based Method for the Functional Assessment of Ube3a Variants.
    Stelzer JA; Yi JJ
    J Vis Exp; 2022 Oct; (188):. PubMed ID: 36282706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.
    Meng L; Ward AJ; Chun S; Bennett CF; Beaudet AL; Rigo F
    Nature; 2015 Feb; 518(7539):409-12. PubMed ID: 25470045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.